생명과학회지 (Journal of Life Science)

  • 제19권2호
  • /
  • Pages.234-240
  • /
  • 2009
  • /
  • 1225-9918(pISSN)
  • /
  • 2287-3406(eISSN)
한국생명과학회 (Korean Society of Life Science)
권호 표지
DOI QR코드

DOI QR Code

부산지역 유흥업소 종사 여성의 HPV 감염 및 유전자형 분포 조사

Prevalence of HPV Infection and HPV Genotype Spectrum among Sexually High-Risk Women in Busan

  • 민상기 (부산광역시보건환경연구원) ;
  • 김성순 (질병관리본부 국립보건연구원 면역병리센터 에이즈.종양바이러스팀) ;
  • 최병선 (질병관리본부 국립보건연구원 면역병리센터 에이즈.종양바이러스팀) ;
  • 조경순 (부산광역시보건환경연구원) ;
  • 이주연 (부산광역시보건환경연구원) ;
  • 김성준 (부산광역시보건환경연구원) ;
  • 빈재훈 (부산광역시보건환경연구원) ;
  • 박호국 (부산광역시보건환경연구원)
  • Min, Sang-Kee (Division of Epidemiology, Busan Institute of Health and Environment) ;
  • Kim, Sung-Soon (Divison of AIDS, Center for Immunology and Pathology, National Institute of Health, Korea Center for Disease Control & Prevention) ;
  • Choi, Byeong-Sun (Divison of AIDS, Center for Immunology and Pathology, National Institute of Health, Korea Center for Disease Control & Prevention) ;
  • Cho, Kyung-Soon (Division of Epidemiology, Busan Institute of Health and Environment) ;
  • Lee, Joo-Yun (Division of Epidemiology, Busan Institute of Health and Environment) ;
  • Kim, Seong-Joon (Division of Epidemiology, Busan Institute of Health and Environment) ;
  • Bin, Jae-Hun (Division of Epidemiology, Busan Institute of Health and Environment) ;
  • Park, Ho-Kuk (Division of Epidemiology, Busan Institute of Health and Environment)
  • 발행 : 2009.02.28
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

부산지역의 유흥업소 종사여성을 대상으로 HPV DNA chip 시험을 통하여 HPV 유병율 및 유전자형 분포를 조사하였다. 총 660건의 자궁경부도찰 검체로부터 258건(양성율 39.1%)이 검출되었으며, 20대에서 가장 높은 유병율을 나타내었다. 양성자의 유전자형 분포는 고위험군 유전자형의 경우 HPV-16 (15.9%), -53 (10.2%), -58 (7.7%), -18 (5.2%)순이었고, 저위험군 유전자형의 경우 HPV-70 (10.4%), -6 (4.1%), -11 Journal of Life Science 2009, Vol. 19. No. 2 239 (2.0%)순이었다. 특이하게 고위험군 감염여성의 분포비(62.0%)가 저위험군(14.7%) 및 고/저위험군 혼합감염(12.0%)보다 4배 가까이 높았다. 전체 양성자중 단일유형 감염자는 175건(67.8%)이고 혼합유형 감염자는 83건(32.2%)이었다. 본 연구 결과 밝혀진 부산지역 유흥업소 종사여성에서 많이 발견되는 HPV 유전자형 분포의 다양성은 국내 도입된 자궁경부암 예방백신의 효과 예측 및 국내 특성에 맞는 다가백신 개발의 기초 자료가 될 수 있을 것으로 사료된다.

We tried to analyze the HPV prevalence and HPV genotypes of sexually high-risk women living in Busan, the biggest seaport of South Korea. Six hundred sixty women engaging in high-risk occupations participated in this study. The prevalence of HPV infection and HPV genotyping were determined with $MyGene^{(R)}$ HPVDNA chip, which consisted of 16 high-risk HPV genotypes (oncogenic genotypes) and 8 low-risk HPV genotypes. The overall prevalence of HPV infection in this study population was 39.1% (258/660) and the 20's showed the highest prevalence of HPV infection (51.5%). The dominant HPV genotypes including single or multiple HPV-infected women were resulted in HPV-16 (15.9%), -53 (10.2%), -58 (7.7%), -18 (5.2%) in case of high-risk HPV genotype and HPV-70 (10.4%), -6 (4.1%), -11 (2.0%) in case of low-risk HPV genotypes. Remarkably, the proportion of women infected with high-risk HPV genotypes (62.0%) was almost four times higher than those of women infected with low-risk HPV genotypes (14.7%) and high/low-risk HPV genotypes (12.0%). Among the 258 HPV-infected women, single infection was 175, double infection 66, triple infection 12, quadruple infection 4, quintuple infection 1, respectively. Our finding suggests that the introduction and development of effective HPV vaccines should consider the current status of HPV genotypic infection in South Korean women.

키워드

참고문헌

  1. Agosti, J. M. and S. J. Goldie. 2007. Introducing HPV vaccine in developing countries. N. Eng. J. Med. 356, 1908-1910 https://doi.org/10.1056/NEJMp078053
  2. An, H. J., N. H. Cho, S. Y. Lee, I. H. Kim, and S. J. Kim. 2003.Correlation of cervical carcinoma and precancerous legions with human papillomavirus (HPV) genotypes detected with the HPV DNA chip microarray method. Cancer 97, 1672-1680 https://doi.org/10.1002/cncr.11235
  3. Bosch, F. X., M. M. Manos, N. Munos, M. Sherman, A. M. Jansen, and J. Peto. 1995. Prevalence of HPV in cervical cancer. J. Natl. Cancer Inst. 87, 796-802 https://doi.org/10.1093/jnci/87.11.796
  4. Castellsague, X., C. Menendez, M. P. Loscertales, J. R. Kornegay, F. Santos, A. Barreto, F. X. Bosch, and P. Alonso. 2001. Human papillomavirus genotypes in rural Mozambique. Lancet 358, 1429-1430 https://doi.org/10.1016/S0140-6736(01)06523-0
  5. Cates, W. Jr. 1999. Estimates of the incidence and prevalence of sexually transmitted disease in the United States: American social health association panel. Sex Transm. Dis. 26, 2-7 https://doi.org/10.1097/00007435-199904001-00002
  6. Chan, P. K., K. H. Mark, J. L. Cheung, N. L. Tang, D. P. Chan, K. K. Lo, and A. F. Cheng. 2002. Genotype spectrum of cervical human papillomavirus infection among sexually transmitted disease clinic patients in Hong Kong. J. Med. Virol. 68, 273-277 https://doi.org/10.1002/jmv.10189
  7. Chen, S., H. O. Sullivan, S. N. Tabrizi, C. K.Fairley, M. A. Quinn, and S. M. Garland. 1999. Prevalence and genotyping of HPV in cervical cancer among Australian women. Int. J. Gynecol. Obstet. 67, 163-168 https://doi.org/10.1016/S0020-7292(99)00167-8
  8. Choi, B. S., O. J. Kim, M. S. Park, K. S. Kim, J. M. Kim, and J. S. Lee. 2003. Genital human papillomavirus genotyping by HPV oligonucleotide microarray in Korean commercial sex workers. J. Med. Virol. 71, 440-445 https://doi.org/10.1002/jmv.10498
  9. Editorial. 1997. Do HPV-negative cervical carcinomas exit?. J. pathol. 181, 253-254 https://doi.org/10.1002/(SICI)1096-9896(199703)181:3<253::AID-PATH755>3.0.CO;2-0
  10. Eduardo, L. P., H. Rolando, M. Nubia, C. Aurelio, V. S. Keerti, A. Patricia, H. Pilar, S. Jorge, and H. Mauricio. 2001. Epidemiology of HPV infection among Mexican women with normal cervical cytology. Int. J. Cancer 91, 412-420 https://doi.org/10.1002/1097-0215(20010201)91:3<412::AID-IJC1071>3.0.CO;2-M
  11. Eileen, F. D. and L. E. Markowitz. 2006. Genital human papillomavirus infection. Clin. Infect. Dis. 43, 624-629 https://doi.org/10.1086/505982
  12. Eileen, F. D., L. K. Kelvin, R. S. Maya, M. S. Ketherine, R. U. Elizabeth, C. R. William, and L. E. Markowitz. 2005. Serovalence of human papillomavirus type 16 in children. J. Infect. Dis. 191, 1817-1819
  13. Eileen, F. D., M. N. Carrie, M. S. Katherine, E. M. Laurie, and R. G. Anna. 2006. Prevalence of HPV infection among man: a systematic review of the literature. J. Infect. Dis. 194, 1044-1057 https://doi.org/10.1086/507432
  14. Eileen, M. Burd. 2003. Human papillomavirus and cervical cancer. Clin. Microbiol. Rev. 16, 1-17 https://doi.org/10.1128/CMR.16.1.1-17.2003
  15. Figueroa, J. P., E. Ward, T. E. Luthi, S. H. Vermund, A. R, Brathwaite, and R. D. Burk. 1995. Prevalence of human papillomavirus among STD clinic attenders in Jamaica. Sex Transm. Dis. 22, 114-118 https://doi.org/10.1097/00007435-199503000-00007
  16. Franco, E. L. and D. M. Harper. 2005. Vaccination against human papillomavirus infection: a new paradigm in cervical cancer control. Vaccine 23, 2388-2394 https://doi.org/10.1016/j.vaccine.2005.01.016
  17. Hwang, T. S., J. K. Jeong, M. Park, H. S. Han, H. K. Choi, and T. S. Park. 2003. Detection and typing of HPV genotypes in various cervical lesions by HPV oligonucleotide microarray. Gynecol. Oncol. 90, 51-56 https://doi.org/10.1016/S0090-8258(03)00201-4
  18. Ishi, K., F. Suzuki, A. Saito, and T. Kubota. 2000. Prevalence of human papillomavirus, Chlamydia trachomatis and Neissera gonorrhoeae in commercial sex workers in Japan. Infect. Dis. Obstet. Gynecol. 8, 235-239
  19. Jung, W. W., T. Chun, D. Sul, K. W. Hwang, H. S. Kang, D. J. Lee, and I. K. Han. 2004. Strategies against human papillomavirus infection and cervical cancer. J. Microbiol. 42, 255-266
  20. Kahng, J. M. and H. J. Lee. 2008. Clinical efficacy of HPVDNA chip test in the era of HPV vaccination. Korean J. Lab. Med. 28, 70-78 https://doi.org/10.3343/kjlm.2008.28.1.70
  21. Kim, K. H., M. S. Yoon, Y. J. Na, C. S. Park, M. R. Oh, and W. C. Moon. 2006. Development evaluation of a highly sensitive human papillomavirus genotyping DNA chip. Gynecol. Oncol. 100, 38-43 https://doi.org/10.1016/j.ygyno.2005.08.024
  22. Kim, Y. T. 2007. Natural history of HPV and carcinogenesis of cervical cancer, Korean J. Obstet. Gynecol. 50, 711-720
  23. Koutsky, L. 1997. Epidermiology of genital human papillomavirus infection. Am. J. Med. 102, 3-8
  24. Lehtinen, M., J. Diller, P. Knekt, T. Luostarinen, A. Aromaa, R. Kirnbauer, P. Koskela, J. Paavonen, R. Peto, J. T. Schiller, and M. Hakama. 1996. Serologically diagnosed infection with human papillomavirus type 16 and risk for subsequent development of cervical carcinoma. BMJ. 312, 537-539 https://doi.org/10.1158/1055-9965
  25. Levi, J. E., B. Kleter, G. V. Wim, C. S. Maria, L. M. Cynthia, M. Regina, L. Iara, and L. J. Doorn. 2002. High prevalence of human papillomavirus (HPV) infections and high frequency of multiple HPV genotypes in human immunodeficiency virus infected women in Brazil. J. Clin. Microbiol. 40, 3341-3345 https://doi.org/10.1128/JCM.40.9.3341-3345.2002
  26. Luis, A. J. F., C. M. Wheeler, J. U. S. Felipe, J. C. G. Carlos, G. Z. M. Laura, G. C. Santa, and H. A. Mauricio. 2001. Human papillomavirus: A highly prevalent sexually transmitted disease agent among female sex workers from Mexico City. Sex Transm. Dis. 28, 125-130 https://doi.org/10.1097/00007435-200103000-00001
  27. Matos, E., D. Loria, G. M. Amestoy, L. Herrera, M. A. Prince, J. Moreno, C. Krunfly, A. J. C. Van Den Brule, C. J. L. M. Meijer, N. Munoz, R. Herrero, and Proyecto Concordia Collaborative Group. 2003. Prevalence oh human papillomavirus infection among in Concordia, Argentina. Sex Transm. Dis. 30, 593-599 https://doi.org/10.1097/01.OLQ.0000085181.25063.6C
  28. Molano, M., H. Posso, E. Weiderpass, M. Ronderos, S. Franceschi, C. J. Meijer, A. Arslan, and N. Munoz. 2002. Prevalence and determinants of HPV infection among Columbian women with normal cytology. Br. J. Cancer 87,324-333 https://doi.org/10.1038/sj.bjc.6600442
  29. Munoz, N. 2003. International Agency for research on cancer multicenter cervical cancer study group. Epidemiologic classfication of human papillomavirus types associated with cervical cancer. N. Eng. J. Med. 348, 518-527 https://doi.org/10.1056/NEJMoa021641
  30. Park, C. S., Y. D. Choi, W. W. Jung, J. H. Nam, and H. S. Choi. 2005. Detection of HPV genotypes in cervical lesions by the HPV DNA chip and sequencing. Gynecol. Oncol. 90, 51-56 https://doi.org/10.1016/S0090-8258(03)00201-4
  31. Shin, H. R., D. H. Lee, R. Herrero, J. S. Smith, S. Vaccarella, S. H. Hong, K. Y. Jung, H. H. Kim, U. D. Park, H. S. Cha, S. Y. Park, A. Touze, N. Munoz, P. J. Snijders, C. J., Meijer, P. Coursaget, and S. Franceschi. 2003. Prevalence of human papillomavirus infection in women in Busan, South Korea. Int. J. Cancer 103, 413-421 https://doi.org/10.1002/ijc.10825
  32. Shin, H. R., S. Franceschi, S. Vaccarella, J. W. Roh, Y. H. Ju, J. K. Oh, H. J. Kong, S. H. Rha, S. I. Jung, J. I. Kim, K. Y. Jung, L. J. van Doorn, and W. Quint. 2004. Prevalence and determinants of genital infection with papillomavirus,in female and male university students in Busan, South Korea. J. Infect. Dis. 190, 468-476 https://doi.org/10.1086/421279
  33. Touze, A., S. Sanjose, P. Coursage, M. R. Almirall, V. Palacio, C. J. Meijer, J. Kornegay, and F. X. Bosch. 2001. Prevalence of anti-human papillomavirus type 16, 18, 31, and 58 virus-like particle in women in the general population and in prostitutes. J. Clin. Microbiol. 39, 4344-4348 https://doi.org/10.1128/JCM.39.12.4344-4348.2001